Oncology & Cancer

Biomaterial-delivered one-two punch boosts cancer immunotherapy

Cancer immunotherapy has brought major improvement in patient survival and quality of life, especially with the success of adoptive T cell and immune checkpoint inhibitor therapies. Unfortunately, in contrast to different ...

Medical research

Why new cancer treatment discoveries are proliferating

In the five years since the FDA's initial approval of chimeric antigen receptor (CAR) T cell therapy, Penn Medicine has gleaned 20 additional approvals related to drugs and techniques to treat or detect cancer.

page 2 from 11